New Product Launches to Bolster the Growth of the Nootropics Market

The global nootropics market is anticipated to grow at a CAGR of 14.1% during the forecast period (2023-2030). New and effective product launches is anticipated to drive the demand for nootropics, thereby is driving the market growth. For instance, in March 2023, Beverage label Savvy launched a nootropic-infused beverage range designed to optimize cognitive performance. The beverage range is available in two variants: Savvy Coffee and Savvy Drink. Savvy Coffee comes in coffee pods and coffee powder, both with biodegradable compostable packaging. 

Browse the full report description of “Nootropics Market Size, Share & Trends Analysis Report by Form (Capsules/ Tablets, Powder, and Drinks), and by Distribution Channel (Online and Offline) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/nootropics-market

Further, in October 2022, Southern California-based nootropics brand Troomy launched its product line of adaptogenic mushroom gummies. Formulated to help support a wide range of lifestyles and functional needs, Troomy Mushroom Gummies are available in a variety of super-powered mushroom blends and flavors. For focus, the company offers Lion's Mane Mushroom Gummies (Tangerine Passionfruit). For Boost, the company offers Cordyceps Mushroom Gummies (Lemon Lime); For Calmness, the company offers Reishi Mushroom Gummies (Pineapple Peach); For effective sleep, the company offers Reishi + Melatonin Gummies (Black Raspberry)

Furthermore, in August 2022, Snack brand Mindright has launched: a “first-of-its-kind” range of popped chips infused with brain-boosting nootropic ingredients. The latest range comes in three flavours – Chili Lime, Cinnamon Churro and Tumeric Ranch. The popped chips are made using the brand’s signature nootropic concoction, which features ginseng, lion’s mane and L-Theanine, as well as vitamins B6, B12 and antioxidants that benefit energy, mood and focus. The chips are made with 100% avocado oil, in place of traditional oils such as canola and soybean.

In May 2022, Solaray announced the launch of Solaray SharpMind: a collection of advanced nootropics expertly crafted with clinically backed nutrients, adaptogens and fermented organic mushrooms designed to support mental and emotional well-being. Five unique formula includes stress, energy, focus, mood, and sleep — offer targeted support for specific cognitive requirements.

Market Coverage

• The market number available for – 2022-2030

• Base year- 2022

• Forecast period- 2023-2030

• Segment Covered- 

o By Form

o By Distribution Channel

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- including Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., and Teva Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Nootropics Market Report Segment

By Form

• Capsules/Tablets
• Powder
• Drinks 

By Distribution Channel

• Online
• Offline

Global Nootropics Market Report Segment by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/nootropics-market